Pay in 4 interest-free payments of $17.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
OAC1 seems to enhance reprogramming efficiency in a unique manner
EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation
Toxins (Basel)
Hopkins CR
Formula: C28H30N2O6S
MBX-2982 - CAS# 1037792-44-1 size:2mg solid OAC1 seems to enhance reprogrammingMBX 2982, also known as SAR 260093, CAS No. 1037792 44 1, is a potential first in class treatment for type 2 diabetes that targets G protein coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose dependent insulin secretion. Preclinical data indicate that MBX 2982 is a potent selective orally active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the
US$ 31.95
US$ 112.50
US$ 499.50
US$ 134.00
US$ 127.50
US$ 149.50
US$ 19.99
US$ 107.50
US$ 34.98
US$ 397.50
US$ 199.00